Introduction to DPPC.CO
DPPPC.CO
Founded in 1996, DPPPC.CO is one of the largest and most innovative manufacturers of active pharmaceutical ingredients (APIs) in Iran and the region. As a knowledge-based company under the TIPICO pharmaceutical group, DPPPC.CO has maintained a strong presence in the industry and has been listed on the Tehran Stock Exchange since 2002.
Advanced Industrial & R&D Infrastructure
With two production plants located in Tehran and Kermanshah and 10 fully equipped manufacturing lines, DPPPC.CO is recognized as a top-tier pharmaceutical producer. Cutting-edge technologies—including glass-lined and stainless-steel reactors, GMP-compliant production lines, clean rooms, quality control (QC) labs, and advanced R&D units—enable the company to meet the highest standards in API production.
Export Potential and Innovation-Driven Growth
In addition to serving domestic demand, DPPPC.CO is expanding its international footprint by offering a wide range of products including APIs, pellets, direct compression (DC) compounds, and low-volume high-value (LVHV) items. With over 38 knowledge-based products launched, the company actively collaborates with universities, research centers, and tech-based enterprises—both in Iran and globally—to foster innovation.
Our Strategy: Innovation, Collaboration, Excellence
DPPPC.CO’s enduring commitment to sustainable development, continuous quality improvement, and acquisition of cutting-edge technical expertise has positioned the company as a symbol of knowledge-based manufacturing and industrial pride.
Vision Statement
To achieve a leading position in the domestic pharmaceutical raw materials and intermediates industry, and to become the top producer of active pharmaceutical ingredients (APIs) within TIPICO Pharmaceutical Investment Holding. This will be accomplished through a steadfast commitment to enhancing production capabilities for high-quality products, driving revenue growth and profitability, fostering innovation and creativity in expanding the product portfolio, and entering new global markets by the year 2026.
Mission Statement
DarouPakhsh Chemical Pharmaceutical Company is firmly committed to contributing to public health and advancing the national pharmaceutical industry by optimizing the production of active pharmaceutical ingredients (APIs) and intermediates in full compliance with GMP standards.
The company’s reputation is built upon delivering products of the highest quality, empowered by a skilled and dedicated workforce regarded as its most valuable asset, and by leveraging cutting-edge technical expertise and modern technologies aligned with global standards and international pharmacopeias across domestic and international markets.
As a proud member of TIPICO Pharmaceutical Investment Holding and an active economic enterprise, DarouPakhsh Chemical Pharmaceutical Company strives to implement group-wide strategies that ensure sustainable financial performance and enhance shareholder value.
